A key Factor for Success of Chinese Commercialization of Medical Device
Chinese Agent is also called
authorized - or in country representative. It is equivalent to
US agent or
UK responsible person. The Chinese agent with business license in China is required for
every
overseas manufacturer
who has no entity in China. One manufacturer can assign as many Chinese agents as needed. However, only one Chinese agent per product is allowed. Chinese agent will be written on
NMPA certificate besides the name of legal manufacturer.
Please don´t be too overwhelmed after successful product approval. It is hundred percent your right to request all final
approval certificates (also "product technical requirement" as annex and type testing report) issued by authority. It facilitates the next
change - and extension registration as essential documents.
• Compilation of the submission dossiers
• Communication with NMPA
• Report of adverse event
• Assistance of the potential inspection by authority
•
Transfer of regulatory update
New
· Upload of UDI-DI and insurance code in Chinese data base
Nice to have
· Assessment to significant change of approved medical device in China
· Prove of IFU and label
It is a dilemma who should actively coordinate adverse event at post market activities. Chinese agent focuses on registration and Distributor focuses on sales. At new issued regulation, NMPA strengthed the role of Chinese agent for adverse event reporting and maintenance of product distribution indirectly (as EU authorized representative).
The manufacturers are aware of reporting adverse event and recalls since 2019. It is easier for domestic manufacturers when the corresponding departments are among the same house. For overseas manufacturers it is far behind required how to coordinate adverse event - and recalls reporting. Chinese distributor should have agreement with Chinese agent how to handle reporting and to rule the accountability. It means that a procedure of receiving -, analysing -, reportig - as well as handling AE and recalls is needed.
We highly recommend to mandate this role with caution to distributor. On the one hand they don’t have the sound regulatory knowledge. In the most cases they find another consulting firm to do product registration. It exists Ping-Pong communication among three parties. On the other hand they oft keep hold of original
NMPA certificate to block the next product registration and even the process of changing Chinese agent.
At Regulations on the Supervision and Administration of Medical Device (State council order 2021/739) it stipulates:
Article 20
Registrants and record holders of medical device shall perform the following duties:
(1) Establish and adapt product quality management system and applies it effectively;
(2) Development of post-marketing studies and risk management plan and to ensure the effective implementation;
(3) Carry out adverse event monitoring and re-evaluation in accordance with the law;
(4) Establish and implement product traceability and recall system;
(5) Other obligations stipulated by the drug regulatory department of the State Council. The domestic legal person designated by overseas manufacturers shall assist the registrant and filing party in fulfilling the obligations stipulated in the preceding paragraph.
domestic legal person = chinese agent
We have experienced many scenarios whom to assign to be Chinese agent. Since electronic certificate of medical device, the classic story that old agent block paper certificate to new agent doesn’t exist.
Advantage:
Consulting has solid regulatory knowledge
Easy Switch to new distributor
Disadvantage:
Annual holding fee to pay for consulting
Complicated for adverse event communication and reporting
Advantage:
Simplified adverse event management
Easy for issues related to medical device
Disadvantage:
Less regulatory experience
Moderate difficulty to switch either new agent or new distributor
In the transition period you can test consulting and distributor who fulfills his responsibility well and then transfer slowly to reliable distributor
Our suggestion:
Scenario 3, if you chose us as regulatory partner, we can support either inexperienced subsidiary or external distributor
A brief administrative change registration is needed in case foreign manufacturer wants to change Chinese agent. The following actions should be considered:
Update label and instruction for use in Chinese
Complete all adverse events with old agent and transfer the account to new agent
Update registering of insurance code and UDI
Ask all electronic product dossiers, info of adverse event, insurance code and UDI from old Chinese agent
Plan of next quality management annual report and periodic risk assessment report
Contact us, we are expert of global registration too.
Dear Sir/Madam,
Thank you for contacting us.
We will answer you as soon as possible.
regards,
CEO
Antonio Lee
Easychinapprov
China, Germany
Frankfurt, Stuttgart Germany
Sun Dong An Plaza, No. 138
Beijing China
info@easychinapprov.com
0049-17638379004
Follow us in Linkedin and Youtube
E-Learning "MyComplinace"
Learning Chinese regulation and global regulatory affairs
Participation possible any time.
Discount during black week 19% ~ 50%
Article:
International market of medical device for Startups,SME
Overseas inspecion starts again
Testing beyond and for registration
Significant changes of medical device in China, EU, MDSAP countries
Meet us in next conference:
Arab health in Dubai, 2025 Jan
Global compliance and training
All Rights Reserve | Easychinapprov